Growth Metrics

Rigel Pharmaceuticals (RIGL) EPS (Basic) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 139.68%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 25.99%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 41.58%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.28%
7 Evaxion A 62.56 Bn 62.54 Bn - 58.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -2.92%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.92%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn 98.95%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 98.95%
Dec 31, 2025 89.60%
Sep 30, 2025 152.46%
Jun 30, 2025 252.03%
Mar 31, 2025 81.71%
Dec 31, 2024 98.20%
Sep 30, 2024 99.30%
Jun 30, 2024 9.14%
Mar 31, 2024 -59.31%
Dec 31, 2023 34.89%
Sep 30, 2023 -60.38%
Jun 30, 2023 -56.05%
Mar 31, 2023 -37.78%
Dec 31, 2022 -213.80%
Sep 30, 2022 -16.26%
Jun 30, 2022 12.64%
Mar 31, 2022 -13.30%
Dec 31, 2021 -108.01%
Sep 30, 2021 5.01%
Jun 30, 2021 20.63%
Mar 31, 2021 49.67%
Dec 31, 2020 15.14%
Sep 30, 2020 17.02%
Jun 30, 2020 14.50%
Mar 31, 2020 44.22%
Dec 31, 2019 14.50%
Sep 30, 2019 33.68%
Jun 30, 2019 7.17%
Mar 31, 2019 16.65%
Dec 31, 2018 28.92%
Sep 30, 2018 -20.51%
Jun 30, 2018 0.00%
Mar 31, 2018 6.80%
Dec 31, 2017 10.37%
Sep 30, 2017 16.45%
Jun 30, 2017 17.98%
Mar 31, 2017 19.59%
Dec 31, 2016 5.57%
Sep 30, 2016 3.85%
Jun 30, 2016 16.75%
Mar 31, 2016 13.15%
Dec 31, 2015 22.43%
Sep 30, 2015 39.43%
Jun 30, 2015 22.97%
Mar 31, 2015 13.10%
Dec 31, 2014 12.25%
Sep 30, 2014 1.35%
Jun 30, 2014 7.80%
Mar 31, 2014 14.50%
Dec 31, 2013 16.81%
Sep 30, 2013 -31.59%
Jun 30, 2013 -35.72%